The reactivity of [(dpp-Bian)Al(H)2Li(THF)3] (1) (dpp-Bian = 1,2-bis[(2,6-diisopropylphenyl)imino]acenaphthene) and [(ArBIG-Bian)Al(H)2Li(THF)4] (2) (ArBIG-Bian = 1,2-bis[(2,6-dibenzhydryl-4-methylphenyl)imino]acenaphthene) toward isocyanates and carbodiimides has been investigated. A treatment of 1 with tert-buthylisocyanate affords the formimidate derivative [(dpp-Bian)Al(μ2-OC(H)NtBu)2Li(THF)] (3). The related [(ArBIG-Bian)Al(μ2-OC(H)NCy)2Li(THF)] (4) and [(ArBIG-Bian)Al((μ-OC(H)NPh)Li(THF)3)(OC(H)NPh)] (5) have been obtained by reacting of 2 with cyclohexyl and phenylisocyanates, respectively. Cyclohexylcarbodiimide reacts with 1 and 2 to give the corresponding amidinate derivatives [(dpp-Bian)Al(CyNC(H)NCy)(μ-CyNC(H)NCy)Li(THF)2] (6) and [(ArBIG-Bian)Al(CyNC(H)NCy)][Li(DME)3] (7). Complexes 3-7 were characterized by IR and NMR spectroscopy. The molecular structures of compounds 3-7 were determined by single-crystal X-ray analysis. Both 1 and 2 serve well as catalysts in the hydroboration of isocyanates and carbodiimides by pinacolborane (HBpin).
No takes yet. Share an insight, caveat, or question.
Koptseva et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: